1. When Using DOPPS Slides

2. DOPPS Slide Use Guidelines

3. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and parathyroid hormone: the Dialysis Outcomes and Practice Patterns Study (DOPPS)

4. Introduction

5. DOPPS Background

6. Methods (1)

7. Methods (2)

8. Table 1. Study sample characteristics at baseline (1)

9. Table 1. Study sample characteristics (2)

10. Serum Calcium by country and DOPPS phase

11. Serum Phosphorus by country and DOPPS phase

12. PTH by country and DOPPS phase

13. All-cause and cardiovascular mortality risk associated with baseline serum calcium

14. All-cause and cardiovascular mortality risk associated with baseline serum phosphorus

15. All-cause and cardiovascular mortality risk associated with baseline PTH

16. Risk for all-cause and cardiovascular mortality associated with DOPPS-derived risk categories for serum calcium, phosphorus and PTH

17. Patient mortality risk associated with 10% more facility patients within each serum PO 4 category versus reference category (3.6-5.0 mg/dL)

18. Risk of all-cause mortality associated with combinations of baseline serum phosphorus and calcium categories by PTH level

19. Recommended mineral metabolism marker levels in Stage 5 CKD according to different professional organizations, and lowest mortality risk categories observed in the DOPPS

20. Results (1)

21. Results (2)

22. Results (3)

23. Conclusions

24. Acknowledgements